← Funding directory

Dated funding evidence

Nuclera

Series C extension · $12M additional (Series C total $87M) · 2026-01-13

Reported round$12M additional (Series C total $87M)Series C extension
Disclosure date
2026-01-13
Reported currency
USD
Companies House
08663936
Evidence sources
1

Company

NucleraCH 08663936
2026-01-13Series C extension$12M additional (Series C total $87M)

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00445
Stage
Series C extension
Round name
Series C extension
Amount
$12M additional (Series C total $87M)
Lead investors
Elevage Medical Technologies
Other investors
Jonathan Milner, British Patient Capital, GK Goh
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details